SMAD3 and neoplasm: In order to investigate the role of T and B cells in inflammation and tumor development in this model, we compared DSS-induced disease in Smad3−/− and Smad3/Rag-DKO mice using two different DSS regimens (single cycle of 1.5% DSS for 7 days or 9 cycles of 1.5% DSS).